PhD projects
Dorien Glorie
Accelerated target identification using preclinical neuroimaging to close the treatment gap in Obsessive Compulsive Disorder (started 01/09/2015).
Julie Ottoy
Development of clinically-feasible strategies for more accurate quantification of amyloid-beta scans (started 01/10/2015).
Stijn Servaes
Combining small animal molecular imaging with next generation neuromodulation to explore novel OCD treatments (01/10/2014 -30/09/2018).
Sven De Bruycker
Predictive imaging biomarkers for drugs targeting the tumor microenvironment in lung cancer (1/10/2013 - 30/09/2017).
Yanina Dockx
Molecular imaging for early response assessment of drugs targeting the PI3K/Akt/mTOR pathway in an HER-2 amplified breast cancer model (1/10/2012 - 30/09/2016)
Filipe Elvas
Development and in vivo evaluation of SPECT/PET tracers for cell death imaging for the assessment of early tumor cell death in response to therapy
Jens Fissers
PET imaging as a potential biomarker for the diagnosis and treatment in Alzheimer’s disease
Lauren Kosten
Multimodal molecular imaging of a rat model for schizophrenia contributing to an integrative understanding of the glutamatergic (mGluR5), neuroinflammatory (TSPO) and phosphodiesterase (PDE10) interplay
Alan Miranda Menchaca
​Molecular brain imaging of unanesthetized and unconstrained small animals (1/10/2013 - 30/09/2017)
Stephan Missault
The role of extracellular matrix proteases MMP-9 and uPA in the development of posttraumatic epilepsy following traumatic brain injury (1/10/2013 - 30/09/2017)
Sara Rapic
Molecular imaging for early response assessment of drugs targeting the PI3K/Akt/mTOR pathway in a colorectal cancer model (1/10/2012 – 30/09/2016)
Ann-Marie Waldron
Development of an in vivo microPET imaging platform for the non-invasive investigation of novel therapeutics in Alzheimer's disease (1/01/2014 - 31/12/2017)
Halima Amhaoul
Characterization of brain inflammation in a chronic epilepsy model by means of post-mortem and in vivo techniques (1/10/2011- 31/12/2015)